Lymphomas (2nd Section)

  • K. Pérez - Equiza C. Albo
  • Published 2001 in Bone Marrow Transplantation

Abstract

according the Bearman scale. Skintoxicity was evaluated on clinical stages. Furthermore we investigated the influence of the Vp16 dose. Results: We found a significant higher rate of toxicity to the kidney in the regimen Bu/Cy/Vp-16 (I=52,4%, II=9,5%) compared to TBI/Cy/Vp-16 (I=24,1%, II=6,9%) (p= 0,022) and BEAM (I=26,7%) (p=0,015). Also a higher rate of… (More)
DOI: 10.1038/sj.bmt.1702957

Topics

Cite this paper

@article{Albo2001LymphomasS, title={Lymphomas (2nd Section)}, author={K. P{\'e}rez - Equiza C. Albo}, journal={Bone Marrow Transplantation}, year={2001}, volume={27}, pages={S268-S270} }